Common denominator that triggers asthma in favorable environments

Some so-called pro-allergic environments strongly promote the development of asthma and are responsible for the dramatic increase in the prevalence of asthma, especially in industrialized countries. Researchers at the GIGA of the University of Liège have identified how all these pro-allergic environments act in the same way on the pulmonary immune system to induce the development of allergic asthma.

Read more

Weak spot in pathogenic bacteria

Antibiotics are still the most important weapon for combatting bacterial infections. But medical science is running out of ''ammunition'' because of more and more frequently occurring resistances. Research teams have now elucidated the structure of the proteolytic complex ClpX-ClpP. This is a key to development of innovative antibiotics which target the degradation process of defective proteins in bacteria.

Read more

Scientists ID new targets to treat fibrosis, a feature of many chronic diseases

When it comes to repairing injured tissue, specialized cells in the body known as fibroblasts are called into action. Fibroblasts give rise to healing cells called myofibroblasts, which generally is good in the short term — but bad when myofibroblast activation gets out of hand. Now, researchers show how fibroblast activation and myofibroblast formation occurs, providing clues for how to target fibrosis — which impacts several chronic diseases.

Read more

Did long ago tsunamis lead to mysterious, tropical fungal outbreak in Pacific northwest?

The Great Alaskan Earthquake of 1964 and the tsunamis it spawned may have washed a tropical fungus ashore, leading to a subsequent outbreak of often-fatal infections among people in coastal regions of the Pacific Northwest, according to a new article.

Read more

Nanoparticles wiggling through mucus may predict severe COPD

In a proof-of-concept experiment, researchers say they have successfully used microscopic human-made particles to predict the severity of patients' chronic obstructive pulmonary disease (COPD) by measuring how quickly the particles move through mucus samples. The technique, say the researchers, could eventually help doctors deliver more effective treatments sooner.

Read more